3-hydroxyflavone has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leo, CH; Woodman, OL | 1 |
| Malakul, W; Woodman, OL | 1 |
| Ghaffari, MA; Mojab, S | 1 |
1 review(s) available for 3-hydroxyflavone and Diabetic Angiopathies
| Article | Year |
|---|---|
Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Agents; Diabetes Mellitus; Diabetic Angiopathies; Disease Models, Animal; Endothelium, Vascular; Flavonols; Humans; Hypoglycemic Agents; Oxidative Stress; Protein Kinase Inhibitors; Signal Transduction; Vasodilation; Vasodilator Agents | 2015 |
2 other study(ies) available for 3-hydroxyflavone and Diabetic Angiopathies
| Article | Year |
|---|---|
3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta.
Topics: Acridines; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Flavonols; In Vitro Techniques; Luminescence; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides | 2009 |
Influence of flavonols as in vitro on low density lipoprotein glycation.
Topics: Adult; Antioxidants; Atherosclerosis; Diabetic Angiopathies; Flavonoids; Flavonols; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Kaempferols; Lipoproteins, LDL; Male; Quercetin; Rutin | 2007 |